Phase 1 Clinical Trials2018-09-04T23:05:13+00:00

Phase 1 Clinical Trials

Clinilabs Drug Development Corporation provides full range of CNS Phase I capabilities, with extensive experience in early phase studies required for regulatory approval. We offer expertise that provides a sound foundation for all Phase I projects.

  • First in human

  • First in class

  • Single ascending dose (SAD)

  • Multiple ascending dose (MAD)

  • Bioequivalence (BE)

  • Drug – drug interaction studies

  • Drug – alcohol interactions studies

  • Food effect studies

  • Pharmacokinetic (PK) studies

  • Pharmacodynamic (PD) studies

  • Kinetic-dynamic relationships

Remember the Three Princes of Serendip who went out looking for treasure? They didn’t find what they were looking for, but they kept finding things just as valuable. That’s serendipity, and our business [drugs] is full of it.

– George W. Merck